{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:22:34Z","timestamp":1794547354924,"version":"4.9.1"},"reference-count":49,"publisher":"American Chemical Society (ACS)","issue":"20","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K16406"],"award-info":[{"award-number":["22K16406"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23H02850"],"award-info":[{"award-number":["23H02850"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K19407"],"award-info":[{"award-number":["25K19407"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025019","name":"Support for Pioneering Research Initiated by the Next Generation","doi-asserted-by":"publisher","award":["JPMJSP2114"],"award-info":[{"award-number":["JPMJSP2114"]}],"id":[{"id":"10.13039\/501100025019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aldosterone synthase (CYP11B2) is overexpressed in aldosterone-producing adenomas (APAs) and represents a promising PET target for the noninvasive localization of APA lesions in primary aldosteronism. To address this need, we synthesized and evaluated 2-pyridinylbenzimidazole analogues for their ability to bind to human APA (hAPA) tissue. Based on initial binding assays, five analogues were selected and radiolabeled with fluorine-18 for autoradiographic and saturation binding studies. Among them, [18F]3 ([18F]ApaScan) exhibited high-affinity binding to hAPA homogenates (KD = 8.4 nM) with no measurable specific binding to normal adrenal (hNA) homogenates, demonstrating excellent tissue selectivity for hAPA over hNA. Quantitative autoradiography using [18F]3 further confirmed a high hAPA-to-hNA tissue binding ratio of 18. In normal rats, [18F]3 displayed rapid adrenal uptake, efficient clearance without prolonged retention, and no skeletal accumulation. Taken together, these results suggest that [18F]3 has the potential to be developed into a PET tracer for localizing APAs in primary aldosteronism.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01084","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:01:49Z","timestamp":1791464509000},"page":"23651-23670","source":"Crossref","is-referenced-by-count":0,"title":["[18F]ApaScan: A 2-Pyridinylbenzimidazole PET Tracer with Highly Selective Binding to Human Aldosterone-Producing Adenoma Tissue"],"prefix":"10.1021","volume":"69","author":[{"given":"Yuki","family":"Shimizu","sequence":"first","affiliation":[{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]},{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruyuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]},{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesshu","family":"Takao","sequence":"additional","affiliation":[{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]},{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8575"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toko","family":"Otaka","sequence":"additional","affiliation":[{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]},{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8575"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Tohoku University Graduate School of Medicine , , ,","place":["Sendai, Japan, 980-8575"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Tezuka","sequence":"additional","affiliation":[{"name":"Tohoku University Hospital , , ,","place":["Sendai, Japan, 980-8574"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoma","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]},{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikiyo","family":"Ono","sequence":"additional","affiliation":[{"name":"Tohoku University Hospital , , ,","place":["Sendai, Japan, 980-8574"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Toyama","sequence":"additional","affiliation":[{"name":"Tohoku University Hospital , , ,","place":["Sendai, Japan, 980-8574"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8538-8814","authenticated-orcid":true,"given":"Ryuichi","family":"Harada","sequence":"additional","affiliation":[{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]},{"name":"Tohoku Medical and Pharmaceutical University , , ,","place":["Sendai, Japan, 983-8536"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Iwata","sequence":"additional","affiliation":[{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitoshi","family":"Satoh","sequence":"additional","affiliation":[{"name":"Tohoku University Graduate School of Medicine , , ,","place":["Sendai, Japan, 980-8575"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Katagiri","sequence":"additional","affiliation":[{"name":"Tohoku University Hospital , , ,","place":["Sendai, Japan, 980-8574"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kaneta","sequence":"additional","affiliation":[{"name":"Tohoku University Hospital , , ,","place":["Sendai, Japan, 980-8574"]},{"name":"Tohoku University Graduate School of Medicine , , ,","place":["Sendai, Japan, 980-8575"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Tohoku University Graduate School of Medicine , , ,","place":["Sendai, Japan, 980-8575"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Takase","sequence":"additional","affiliation":[{"name":"Tohoku University Hospital , , ,","place":["Sendai, Japan, 980-8574"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[{"name":"Tohoku University Graduate School of Medicine , , ,","place":["Sendai, Japan, 980-8575"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9296-3079","authenticated-orcid":true,"given":"Shozo","family":"Furumoto","sequence":"additional","affiliation":[{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]},{"name":"Tohoku University , , ,","place":["Sendai, Japan, 980-8578"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"10","key":"2026102305074370400_cit1","doi-asserted-by":"publisher","first-page":"102791","DOI":"10.1016\/j.cpcardiol.2024.102791","article-title":"Global and regional prevalence and cardiovascular risk of primary aldosteronism: a systematic review and meta-analysis","volume":"49","author":"Huang","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"11","key":"2026102305074370400_cit2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism - a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"2026102305074370400_cit3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41581-023-00753-6","article-title":"Primary aldosteronism: molecular medicine meets public health","volume":"19","author":"Azizan","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2026102305074370400_cit4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026102305074370400_cit5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/hjh.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"issue":"1","key":"2026102305074370400_cit6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International Histopathology Consensus for Unilateral Primary Aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026102305074370400_cit7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/hypertensionaha.118.11086","article-title":"Cellular and Genetic Causes of Idiopathic Hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"key":"2026102305074370400_cit8","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/EJE-22-0123","article-title":"True unilateral primary aldosteronism exists, and unilateral adrenalectomy saves lives","volume":"186","author":"Reincke","year":"2022","journal-title":"Eur. J. Endocrinol."},{"key":"2026102305074370400_cit9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0279682","article-title":"Ectopic localization of CYP11B1- and CYP11B2-expressing cells in the normal human adrenal gland","volume":"17","author":"Duparc","year":"2022","journal-title":"PLoS One"},{"issue":"12","key":"2026102305074370400_cit10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/s2213-8587(25)00263-3","article-title":"Post-treatment renin status and cardiovascular, renal, and mortality outcomes in medically treated primary aldosteronism: a systematic review and meta-analysis","volume":"13","author":"Katsuragawa","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2026102305074370400_cit11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1210\/endrev\/bnad024","article-title":"Biomarkers to Guide Medical Therapy in Primary Aldosteronism","volume":"45","author":"Hundemer","year":"2024","journal-title":"Endocr Rev"},{"issue":"9","key":"2026102305074370400_cit12","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026102305074370400_cit13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021","volume":"69","author":"Naruse","year":"2022","journal-title":"Endocr J"},{"key":"2026102305074370400_cit14","doi-asserted-by":"publisher","first-page":"1336306","DOI":"10.3389\/fendo.2024.1336306","article-title":"Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism","volume":"15","author":"Araujo-Castro","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026102305074370400_cit15","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"issue":"1","key":"2026102305074370400_cit16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1148\/radiol.2015142159","article-title":"Intra-adrenal Aldosterone Secretion: Segmental Adrenal Venous Sampling for Localization","volume":"278","author":"Satani","year":"2016","journal-title":"Radiology"},{"issue":"5","key":"2026102305074370400_cit17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1161\/hypertensionaha.110.168484","article-title":"Adrenal venous sampling: evaluation of the German Conn\u2019s registry","volume":"57","author":"Vonend","year":"2011","journal-title":"Hypertension"},{"issue":"3","key":"2026102305074370400_cit18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12020-020-02474-3","article-title":"11C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature","volume":"70","author":"Chen Cardenas","year":"2020","journal-title":"Endocrine"},{"issue":"1","key":"2026102305074370400_cit19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13550-024-01109-2","article-title":"Radiation dosimetry of para-chloro-2-[18F]fluoroethyl-etomidate: a PET tracer for adrenocortical imaging","volume":"14","author":"Silins","year":"2024","journal-title":"EJNMMI Res"},{"issue":"10","key":"2026102305074370400_cit20","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s00259-003-1252-8","article-title":"In vivo and in vitro evaluation of [18F]FETO with respect to the adrenocortical and GABAergic system in rats","volume":"30","author":"Mitterhauser","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"2026102305074370400_cit21","first-page":"982","article-title":"In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors","volume":"39","author":"Bergstro\u0308m","year":"1998","journal-title":"J Nucl Med"},{"issue":"10","key":"2026102305074370400_cit22","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.7150\/ijms.51206","article-title":"Para-chloro-2-[18F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging","volume":"18","author":"Silins","year":"2021","journal-title":"Int J Med Sci"},{"key":"2026102305074370400_cit23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nucmedbio.2018.11.002","article-title":"Development of [18F]FAMTO: A novel fluorine-18 labelled positron emission tomography (PET) radiotracer for imaging CYP11B1 and CYP11B2 enzymes in adrenal glands","volume":"68-69","author":"Bongarzone","year":"2019","journal-title":"Nucl Med Biol"},{"issue":"3","key":"2026102305074370400_cit24","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1210\/jc.2015-3431","article-title":"A Novel CYP11B2-Specific Imaging Agent for Detection of Unilateral Subtypes of Primary Aldosteronism","volume":"101","author":"Abe","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"2026102305074370400_cit25","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1021\/acs.jmedchem.1c00539","article-title":"Development of [18F]AldoView as the First Highly Selective Aldosterone Synthase PET Tracer for Imaging of Primary Hyperaldosteronism","volume":"64","author":"Sander","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"issue":"21","key":"2026102305074370400_cit26","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1056\/NEJMc2507481","article-title":"Adrenal Aldosterone Synthase Expression Imaging in Primary Aldosteronism","volume":"393","author":"\u00c5rstad","year":"2025","journal-title":"N Engl J Med"},{"key":"2026102305074370400_cit27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/rlu.0000000000006014","article-title":"First-in-Human Evaluation of [18F]AldoView: A Highly Selective PET Tracer for Aldosterone Synthase Imaging in Primary Aldosteronism","volume":"50","author":"Long","year":"2025","journal-title":"Clin Nucl Med"},{"key":"2026102305074370400_cit28","article-title":"Aldosterone synthase inhibitors","author":"Hoyt","year":"26, 2012","journal-title":"WO 2012\/012478 A1"},{"key":"2026102305074370400_cit29","doi-asserted-by":"publisher","volume-title":"Test No. 107: Partition Coefficient (n-octanol\/water): Shake Flask Method","year":"1995","DOI":"10.1787\/9789264069626-en"},{"key":"2026102305074370400_cit30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.apradiso.2017.04.021","article-title":"Minimization of the amount of Kryptofix 222 - KHCO3 for applications to microscale 18F-radiolabeling","volume":"125","author":"Iwata","year":"2017","journal-title":"Appl Radiat Isot"},{"issue":"4","key":"2026102305074370400_cit31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.nucmedbio.2009.01.014","article-title":"18F-labelled metomidate analogues as adrenocortical imaging agents","volume":"36","author":"Erlandsson","year":"2009","journal-title":"Nucl Med Biol"},{"issue":"1","key":"2026102305074370400_cit32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/cen.15139","article-title":"Adrenal Vein Sampling for Primary Aldosteronism: Recommendations From the Australian and New Zealand Working Group","volume":"102","author":"Yang","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2026102305074370400_cit33","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/ijms18040848","article-title":"Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary?","volume":"18","author":"Buffolo","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026102305074370400_cit34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1210\/endrev\/bnad026","article-title":"Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks","volume":"45","author":"Mullen","year":"2024","journal-title":"Endocr Rev"},{"issue":"35","key":"2026102305074370400_cit35","doi-asserted-by":"publisher","first-page":"20961","DOI":"10.1016\/s0021-9258(19)30030-4","article-title":"Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta)","volume":"264","author":"Mornet","year":"1989","journal-title":"J Biol Chem"},{"key":"2026102305074370400_cit36","doi-asserted-by":"publisher","first-page":"751770","DOI":"10.3389\/fmolb.2021.751770","article-title":"Immunohistochemical Analysis of CYP11B2, CYP11B1 and beta-catenin Helps Subtyping and Relates With Clinical Characteristics of Unilateral Primary Aldosteronism","volume":"8","author":"Sun","year":"2021","journal-title":"Front Mol Biosci"},{"key":"2026102305074370400_cit37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/cen.14628","article-title":"Expression of CYP11B1 and CYP11B2 in adrenal adenoma correlates with clinical characteristics of primary aldosteronism","volume":"96","author":"Ahn","year":"2022","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"2026102305074370400_cit38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/bc500475e","article-title":"Fluorine-18 radiochemistry, labeling strategies and synthetic routes","volume":"26","author":"Jacobson","year":"2015","journal-title":"Bioconjug Chem"},{"key":"2026102305074370400_cit39","doi-asserted-by":"crossref","first-page":"108238","DOI":"10.1016\/j.jmgm.2022.108238","article-title":"In silico selectivity modeling of pyridine and pyrimidine based CYP11B1 and CYP11B2 inhibitors: A case study","volume":"116","author":"Matore","year":"2022","journal-title":"Journal of Molecular Graphics and Modelling"},{"issue":"12","key":"2026102305074370400_cit40","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1021\/jm401430e","article-title":"Aldosterone Synthase Inhibitors as Promising Treatments for Mineralocorticoid Dependent Cardiovascular and Renal Diseases","volume":"57","author":"Hu","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"issue":"5","key":"2026102305074370400_cit41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1021\/acsmedchemlett.5b00054","article-title":"Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys","volume":"6","author":"Hoyt","year":"2015","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"4","key":"2026102305074370400_cit42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jlcr.680","article-title":"Synthesis of [18F]FETO, a novel potential 11-\u03b2 hydroxylase inhibitor","volume":"46","author":"Wadsak","year":"2003","journal-title":"Journal of Labelled Compounds and Radiopharmaceuticals"},{"issue":"8","key":"2026102305074370400_cit43","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1210\/en.2003-0109","article-title":"Regulation of Aldosterone Synthase Gene Expression in the Rat Adrenal Gland and Central Nervous System by Sodium and Angiotensin II","volume":"144","author":"Ye","year":"2003","journal-title":"Endocrinology"},{"issue":"5","key":"2026102305074370400_cit44","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1210\/endo.130.5.1572304","article-title":"Zone-specific expression of aldosterone synthase cytochrome P-450 and cytochrome P-45011 beta in rat adrenal cortex: histochemical basis for the functional zonation","volume":"130","author":"Ogishima","year":"1992","journal-title":"Endocrinology"},{"key":"2026102305074370400_cit45","doi-asserted-by":"publisher","first-page":"109621","DOI":"10.1016\/j.nucmedbio.2026.109621","article-title":"Automated cassette-based synthesis, metabolism, and dosimetry of [18F]ApaScan, a PET tracer for aldosterone synthase imaging","volume":"156\u2212157","author":"Shimizu","year":"2026","journal-title":"Nucl Med Biol"},{"issue":"1","key":"2026102305074370400_cit46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1124\/jpet.110.167148","article-title":"Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone","volume":"334","author":"Rigel","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"2026102305074370400_cit47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jsbmb.2015.08.004","article-title":"Development of CYP11B1 and CYP11B2 assays utilizing homogenates of adrenal glands: Utility of monkey as a surrogate for human","volume":"154","author":"Cerny","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"2026102305074370400_cit48","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.2967\/jnumed.112.117341","article-title":"Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease","volume":"54","author":"Okamura","year":"2013","journal-title":"J Nucl Med"},{"issue":"1-2","key":"2026102305074370400_cit49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Molecular and Cellular Endocrinology"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01084","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23651\/68782342\/jm6c01084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/69\/20\/23651\/68782342\/jm6c01084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:22:06Z","timestamp":1794543726000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/69\/20\/23651\/5446783\/18F-ApaScan-A-2-Pyridinylbenzimidazole-PET-Tracer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":49,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2026,10,8]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01084","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01084.s003","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]}}}